HEALTHCARE COSTS OF NOT ACHIEVING REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Bergman, M. [1 ]
Zhou, L. [2 ]
Patel, P. [2 ]
Sawant, R. [2 ]
Clewell, J. [2 ]
Tundia, N. [2 ]
机构：
[1] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[2] AbbVie Inc, N Chicago, IL USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.955
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0546
引用
收藏
页码：509 / 509
页数：1
相关论文
共 50 条
  • [31] PREDICTORS OF ACHIEVING STRINGENT REMISSION IN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS IN CLINICAL REMISSION FOLLOWING A TREAT-TO-TARGET STRATEGY
    Moller-Bisgaard, S.
    Georgiadis, S.
    Horslev-Petersen, K.
    Ejbjerg, B.
    Hetland, M. L.
    Ornbjerg, L.
    Glinatsi, D.
    Moller, J. Mollenbach
    Boesen, M.
    Stengaard-Pedersen, K.
    Madsen, O. Rintek
    Jensen, B.
    Villadsen, J.
    Hauge, E. M.
    Bennett, P.
    Hendricks, O.
    Asmussen, K.
    Kowalski, M.
    Lindegaard, M.
    Bliddal, H.
    Krogh, N. Steen
    Ellingsen, T.
    Nielsen, A.
    Balding, L.
    Jurik, A. G.
    Thomsen, H.
    Ostergaard, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1401 - 1401
  • [32] Biologics can be sold in rheumatoid Arthritis afther Achieving Remission? Pro
    Rubbert-Roth, A.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (33) : 1674 - 1674
  • [33] ADALIMUMAB DISCONTINUATION IN PATIENTSWITH RHEUMATOID ARTHRITIS AFTER ACHIEVING SUSTAINED REMISSION
    Demidova, Natalia
    Savushkina, Natalia
    Galushko, Elena
    Gordeev, Andrey
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1647 - 1647
  • [34] Achieving comprehensive remission or low disease activity in rheumatoid patients and its impact on workability - Saudi Rheumatoid Arthritis Registry
    Almoallim, Hani
    Janoudi, Nahid
    Alokaily, Fandah
    Alzahrani, Zeyad
    Algohary, Shereen
    Alosaimi, Hanan
    Attar, Suzan
    [J]. OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2019, 11 : 89 - 95
  • [35] Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis Changing Biologics in the USA
    Chastek, Benjamin
    Chen, Chieh-I
    Proudfoot, Clare
    Shinde, Shraddha
    Kuznik, Andreas
    Wei, Wenhui
    [J]. ADVANCES IN THERAPY, 2017, 34 (11) : 2422 - 2435
  • [36] Comparing biologic persistence and healthcare costs in rheumatoid arthritis patients initiating subcutaneous biologics
    Nadkarni, Anagha
    McMorrow, Donna
    Fowler, Robert
    Smith, David
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2017, 6 (08) : 659 - 669
  • [37] THE TREATMENT OF RHEUMATOID-ARTHRITIS PATIENTS IN REMISSION
    SOROKA, NF
    [J]. KLINICHESKAYA MEDITSINA, 1992, 70 (11-12): : 37 - 39
  • [38] The Economic Benefit of Remission for Patients with Rheumatoid Arthritis
    Curtis, Jeffrey R.
    Fox, Kathleen M.
    Xie, Fenglong
    Su, Yujie
    Collier, David
    Clinton, Cassie
    Oko-Osi, Hafiz
    [J]. RHEUMATOLOGY AND THERAPY, 2022, 9 (05) : 1329 - 1345
  • [39] Remission in Patients with rheumatoid Arthritis: Fewer Infections
    不详
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2018, 77 (06): : 449 - 449
  • [40] Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis Changing Biologics in the USA
    Benjamin Chastek
    Chieh-I Chen
    Clare Proudfoot
    Shraddha Shinde
    Andreas Kuznik
    Wenhui Wei
    [J]. Advances in Therapy, 2017, 34 : 2422 - 2435
12345